Gynecological management of premenstrual symptoms

Current Pain and Headache Reports

Volumn 14, Issue 5, 2010, Pages 367-375

  Shulman, Lee P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Hormones; Premenstrual dysphoric disorder; Premenstrual molimina; Premenstrual syndrome; Serotonin

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CALCIUM; CLONAZEPAM; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL; ESTROGEN; FLUOXETINE; GESTAGEN; GINKGO BILOBA EXTRACT; GONADORELIN; HYPERICUM PERFORATUM EXTRACT; LEUPRORELIN; LEVONORGESTREL; MAGNESIUM; MEDROXYPROGESTERONE ACETATE; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PLACEBO; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SEX HORMONE; SPIRONOLACTONE; UNINDEXED DRUG; VITEX AGNUS CASTUS EXTRACT;

ABDOMINAL PAIN; ADD ON THERAPY; ANXIETY DISORDER; BEHAVIOR DISORDER; BLOATING; BREAST TENDERNESS; CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE SEVERITY; DRUG MEGADOSE; GYNECOLOGIC CARE; HUMAN; LIFESTYLE MODIFICATION; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD DISORDER; PAIN; PATHOGENESIS; PHYSICAL DISEASE; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; REVIEW; SYMPTOM; THEORY;

EID: 77957132231     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0131-9     Document Type: Review

References (43)

1. B Kessel 2000 Premenstrual syndrome. Advances in diagnosis and treatment Obstet Gynecol Clin North Am 27 625 639 1:STN:280:DC%2BD3M%2FmtFCktA%3D%3D 10.1016/S0889-8545(05)70160-1 10958008
2. American Psychiatric Association (APA): Premenstrual dysphoric disorder. In Diagnostic and Statistical and Manual of Mental Disorders, Text Revision, edn 4. Washington, DC: American Psychiatric Association; 2000:771-774.
3. U Halbreich T Backstrom E Eriksson, et al. 2007 Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies Gynecol Endocrinol 23 123 130 10.1080/09513590601167969 17454164
4. U Halbreich J Borenstein T Pearlstein LS Kahn 2003 The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) Psychoneuroendocrinology 28 Suppl 3 1 23 1:CAS:528:DC%2BD3sXitVynur4%3D
5. LAJ Heinemann TD Minh A Filonenko K Uhl-Hochgräber 2010 Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity Womens Health Issues 20 58 65 10.1016/j.whi.2009.09.005 20123176 This is an important study demonstrating the considerable economic impact of premenstrual symptoms, given the increasing role of reproductive-aged women in the work force
6. L Huo RE Straub C Roca, et al. 2007 Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene Biol Psychiatry 62 925 933 1:CAS:528:DC%2BD2sXhtFerur3E 10.1016/j.biopsych.2006.12.019 17599809 This is an interesting study of a potential genetic etiology for PMDD
7. O Eriksson T Bäckström M Stridsberg, et al. 2006 Differential response to estrogen challenge test in women with and with premenstrual dysphoria Psychoneuroendocrinology 31 415 427 1:CAS:528:DC%2BD28Xit1Oiurk%3D 10.1016/j.psyneuen.2005.10.004 16359822
8. • Duvan CI, Cumaoglu A, Turhan NO, et al.: Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet 2010 Jan 19. This is a recent study presenting interesting information concerning novel physiologic changes associated with PMS doi: 10.1007/s00404-009-1347-y.
9. T Pearlstein M Steiner 2008 Premenstrual dysphoric disorder: burden of illness and treatment update J Psychiatry Neurosci 33 291 301 18592027
10. L Dennerstein P Lehert TC Bäckström K Heinemann 2009 Premenstrual symptoms-severity, duration and typology: an international cross-sectional study Menopause Int 15 120 126 10.1258/mi.2009.009030 19723682 This is an important study showing the critical need for prospective diary information rather than retrospective recall in making accurate diagnoses and monitoring clinical outcomes
11. N Panay 2009 Management of premenstrual syndrome J Fam Plann Reprod Health Care 35 187 194 10.1783/147118909788708147 19622211
12. JC Prior Y Vigna N Alojada 1986 Conditioning exercise decreases premenstrual symptoms. A prospective controlled three month trial Eur J Appl Physiol Occup Physiol 55 349 355 1:STN:280:DyaL2s%2FgsVGrsw%3D%3D 10.1007/BF00422732 3758033
13. SR Johnson 2004 Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners Obstet Gynecol 104 845 859 15458909
14. K Blake P Salkovskis D Gath, et al. 1998 Cognitive therapy for premenstrual syndrome: a controlled trial J Psychosom Res 45 307 318 1:STN:280:DyaK1M%2FgvVCjug%3D%3D 10.1016/S0022-3999(98)00042-7 9794277
15. MS Hunter JM Ussher SJ Browne, et al. 2002 A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder J Psychosom Obstet Gynaecol 23 193 199 1:STN:280:DC%2BD38nnslSisQ%3D%3D 10.3109/01674820209074672 12436805
16. KM Wyatt PW Dimmock PW Jones PM Shaughn O'Brien 1999 Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review BMJ 318 1375 1381 1:CAS:528:DyaK1MXjsl2lsLo%3D 10334745
17. SE Geller LP Shulman RB van Breeman, et al. 2009 Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial Menopause 16 1156 1166 10.1097/gme.0b013e3181ace49b 19609225
18. DM Ribnicky A Poulev B Schmidt, et al. 2008 Evaluation of botanicals for improving human health Am J Clin Nutr 87 Suppl 472S 475S 1:CAS:528: DC%2BD1cXitFajs70%3D 18258641
19. T Low Dog 2005 Menopause: a review of botanical dietary supplements Am J Med 118 Suppl 12B 98 108 10.1016/j.amjmed.2005.09.044 16414334
20. Z He R Chen Y Zhou, et al. 2009 Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomized, multi-center placebo controlled study in China Maturitas 63 99 103 10.1016/j.maturitas.2009.01.006 19269753 This is a recent and robust clinical trial showing symptom improvements in women with premenstrual symptoms using an extract of the fruit of vitex agnus castus (chasteberry)
21. R Schellenberg 2001 Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo-controlled study BMJ 322 134 137 1:STN:280:DC%2BD3M7jsVWnug%3D%3D 10.1136/bmj.322.7279.134 11159568
22. MD van Die KM Bone HG Burger, et al. 2009 Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in later-perimenopausal women: findings from a subpopulation analysis J Altern Complement Med 15 1045 1048 10.1089/acm.2008.0539 19757982
23. G Ozgoli EA Selselei F Mojab HA Majd 2009 A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome J Altern Complement Med 15 845 851 10.1089/acm.2008.0493 19678774
24. NR Shah JB Jones J Aperi, et al. 2008 Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis Obstet Gynecol 111 1175 1182 1:CAS:528:DC%2BD1cXmsVyksbg%3D 18448752 This is an important and recent paper showing the clinical importance of SSRIs for the treatment of PMS and PMDD
25. AJ Rapkin 2005 New treatment approaches for premenstrual disorders Am J Manag Care 11 S480 S491 16336057
26. M Steiner T Pearlstein LS Cohen, et al. 2006 Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs J Womens Health 15 57 69 10.1089/jwh.2006.15.57
27. M Steiner SJ Romano S Babcock, et al. 2001 The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder BJOG 108 462 468 1:CAS:528:DC%2BD3MXktVOks7k%3D 10.1016/S0306-5456(00)00120-0 11368130
28. JM Ferguson 2001 SSRI antidepressant medications: adverse effects and tolerability Prim Care Companion J Clin Psychiatry 3 22 27 10.4088/PCC.v03n0105 15014625
29. Association of Reproductive Health Professionals (ARHP): Managing Premenstrual Symptoms. A Quick Reference Guide for Clinicians. Washington, D.C.: June, 2008.
30. CS Brown FW Ling RN Andersen, et al. 1994 Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial Obstet Gynecol 84 779 786 1:STN:280:DyaK2M%2Fit1Crug%3D%3D 7936512
31. C Guille S Spencer I Cavus CN Epperson 2008 The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment Epilepsy Behav 13 12 24 10.1016/j.yebeh.2008.02.004 18346939
32. KN Muse NS Cetel LA Futterman SC Yen 1984 The premenstrual syndrome. Effects of "medical ovariectomy." N Engl J Med 311 1345 1349 1:STN:280:DyaL2M%2Fjs1Ggsg%3D%3D 10.1056/NEJM198411223112104 6387488
33. H Joffe LS Cohen BL Harlow 2003 Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration Am J Obstet Gynecol 189 1523 1530 1:CAS:528:DC%2BD2cXpvF2ntA%3D%3D 10.1016/S0002-9378(03) 00927-X 14710055
34. SB Usman R Indusekhar S O'Brien 2008 Hormonal management of premenstrual syndrome Best Prac Res Clin Obstet Gynecol 22 251 260 10.1016/j.bpobgyn.2007.07. 001
35. KA Yonkers C Brown TB Pearlstein, et al. 2005 Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder Obstet Gynecol 106 492 501 1:CAS:528:DC%2BD2MXhtVemtrrL 16135578
36. TB Pearlstein GA Bachmann HA Zacur KA Yonkers 2005 Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation Contraception 72 414 421 1:CAS:528:DC%2BD2MXht1Ght7nJ 10.1016/j.contraception.2005.08.021 16307962
37. The American College of Obstetricians and Gynecologists 2010 Practice Bulletin No. 110: Noncontraceptive uses of hormonal contraceptives Obstet Gynecol 115 206 218 10.1097/AOG.0b013e3181cb50b5
38. KM Wyatt PW Dimmock PW Jones, et al. 2001 Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review BMJ 323 1 8 10.1136/bmj.323.7303.1
39. O Ford A Lethaby H Roberts BW Mol 2009 Progesterone for premenstrual syndrome Cochrane Database Syst Rev 15 CD003415 This is another comprehensive overview by the Cochrane group showing no beneficial impact of progestin- or progesterone-only therapies
40. NR Watson JWW Studd M Savvas, et al. 1989 Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone Lancet 2 730 732 1:STN:280:DyaL1MzotlOgsw%3D%3D 10.1016/S0140-6736(89)90784-8 2570971
41. RNJ Smith JWW Studd D Zambiera EF Holland 1995 A randomised comparison over 8 months of 100 mg and 200 mg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome Br J Obstet Gynaecol 102 475 484 1:STN:280:DyaK2MzlvFSqtg%3D%3D 7632640
42. KM Wyatt PW Dimmock KM Ismail, et al. 2004 The effectiveness of GnRHa with and without "add-back" therapy in treating premenstrual syndrome: a meta-analysis Br J Obstet Gynaecol 111 585 593 1:CAS:528:DC%2BD2cXls1Gmur8%3D
43. The American College of Obstetricians and Gynecologists 2000 Practice Bulletin No. 15: Premenstrual syndrome Obstet Gynecol 95 1 9 10.1016/S0029-7844(99)00580-3